- Home
- RDHL vs ALP Comparison
RDHL vs ALP Comparison
Compare RDHL & ALP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.81
Company Overview
Basic Information| Metric | RDHL | ALP |
|---|---|---|
| Founded | 2009 | N/A |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 6.4M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | RDHL | ALP |
|---|---|---|
| Price | $0.81 | N/A |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 148.8K | N/A |
| Earning Date | 04-27-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $381.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.71 | N/A |
| 52 Week High | $3.31 | N/A |
Technical Indicators
Market Signals| Indicator | RDHL | ALP |
|---|---|---|
| Relative Strength Index (RSI) | 40.38 | N/A |
| Support Level | $0.76 | N/A |
| Resistance Level | $0.89 | N/A |
| Average True Range (ATR) | 0.08 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 12.08 | 0.00 |
Price Performance
Historical Comparison RDHL
ALP
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.